Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Bio Medica Laboratories Ltd (BMLL) is currently trading at 138.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Bio Medica Laboratories Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Bio Medica Laboratories Ltd has traded between a low of ₹101.50 and a high of ₹148.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Bio Medica Laboratories Ltd has a market capitalization of approximately 174.42. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Bio Medica Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 174.42 Cr, Bio Medica Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Bio Medica Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Bio Medica Laboratories Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Pharmaceuticals & Biotechnology
Pharmaceuticals
174 Cr
High Risk
0.0
36.7
—
2.8
148.00
101.50
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
6
Neutral
8
Bullish
0
Bearish
9
Neutral
25
Bullish
12
Bearish
3
Neutral
17
Bullish
12
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
149.00 | 183 Cr | 27.28 | 3.79 | 0.00 | 13.87 | 16.29 | 7.62 | ||
164.20 | 183 Cr | 18.87 | 3.34 | 0.00 | 17.67 | 20.78 | 12.61 | ||
138.70 | 174 Cr | — | 2.82 | 0.00 | 66.48 | 47.70 | 0.00 | ||
7.14 | 171 Cr | 714.00 | 4.87 | 0.00 | 0.90 | 1.13 | 0.76 | ||
11.40 | 167 Cr | 57.00 | 14.11 | 0.00 | 15.34 | 21.17 | 8.18 | ||
185.00 | 163 Cr | 12.47 | 2.28 | 0.00 | 18.31 | 18.42 | 13.68 | ||
139.00 | 161 Cr | 12.57 | 1.69 | 0.00 | 12.38 | 12.15 | 5.18 | ||
| Median: 7 Co. | — | 139.00 | 171 Cr | 23.08 | 3.34 | 0.00 | 15.34 | 18.42 | 7.62 |
Regulatory/Compliance Filing
Bio Medica Laboratories Ltd submitted voting results and the scrutinizer's report for the postal ballot dated 23-07-2026; shareholders passed a special resolution to alter the main objects clause of the Memorandum of Association.
Regulatory/Compliance Filing
Bio Medica Laboratories Ltd submitted SDD compliance certificate under Regulation 3(5) & 3(6) of SEBI (PIT) Regulations for quarter ended 2026-06-30, confirming SDD maintained and three UPSI events were captured.
